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Abstract
Background: The association of Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) common variants (rs4402960
and rs1470579) with type 2 diabetes (T2D) has been performed in different populations. The aim of this study was to
evaluate the association of alternative variants of IGF2BP2; rs6777038, rs16860234 and rs7651090 with glutamic acid
decarboxylase antibodies (GADA) negative diabetes in Malaysian Subjects.
Methods/Principal Findings: IGF2BP2; rs6777038, rs16860234 and rs7651090 single nucleotide polymorphisms (SNPs) were
genotyped in 1107 GADA negative diabetic patients and 620 control subjects of Asian from Malaysia. The additive genetic
model adjusted for age, race, gender and BMI showed that alternative variants; rs6777038, rs16860234 and rs7651090 of
IGF2BP2 associated with GADA negative diabetes (OR= 1.21; 1.36; 1.35, P = 0.03; 0.0004; 0.0002, respectively). In addition,
the CCG haplotype and diplotype CCG-TCG increased the risk of diabetes (OR= 1.51, P = 0.01; OR= 2.36, P = 0.009,
respectively).
Conclusions/Significance: IGF2BP2 alternative variants were associated with GADA negative diabetes. The IGF2BP2
haplotypes and diplotypes increased the risk of diabetes in Malaysian subject.
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Introduction
Diabetes mellitus is a quickly emergent public health problem
with a tremendous impact on morbidity and premature mortality
worldwide. It is a complicated heterogeneous metabolic disorder
that affects 366 million people worldwide (6.4% of the world’s
adult population aged between 20–79 years). This number will be
increased to 552 million by 2030 [1]. More than 2.03 million of
Malaysians have diabetes mellitus (11.66% of the Malaysian’s
adult population) [1]. Among T2D patients, Latent Autoimmune
Diabetes of Adults (LADA) occurs in 2.8–22.3% of individuals
[2,3,4]. LADA can be distinguished with evidence of GADA
positivity in adult diabetic patients who clinically resemble T2D at
diagnosis [2,5,6] and do not initially require insulin for at least 6
months [7].
It is widely accepted that interactions between multiple
environmental and genetic factors contribute to the initiation
and progression of T2D [8,9,10]. Several genes those are
associated with T2D in more than one population. However,
subsequent association studies showed some variants that were
highly associated with T2D in one group of subjects were not
associated in other. GWA studies on Caucasians revealed that
IGF2BP2 is a candidate risk gene for T2D
[11,12,13,14,15,16,17,18].
The majority of subsequent association studies of IGF2BP2 with
T2D were focused on intron 2 SNPs; rs4402960 and rs1470579
[10,13,19,20,21,22,23,24,25,26,27,28,29]. It is becoming clear
that single susceptibility locus is not shared among all ethnic
groups. In addition, haplotype variation in populations may
indicate different SNPs within IGF22BP2 gene that may be
associated with T2D, which might be located at a distance
downstream or upstream of the most common variants. However,
there are limited studies on the association of IGF2BP2 alternative
variant; rs6777038, rs16860234 and rs7651090. The aim of this
study was to evaluate the association of alternative variations
within IGF2BP2 gene with GADA negative diabetes in Malaysian
subjects.
Materials and Methods
Ethnic Statement
This study was approved by the local Medical Ethics
Committee of University Malaya Medical Centre. Written
informed consent was obtained from each participant.
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Subjects and Data Collection
Case-control study was conducted at the University Malaya
Medical Centre (UMMC) Kuala Lumpur. The patients previously
diagnosed with T2D who attended the UMMC for treatment were
invited to participate in this study (case group). For the control
group, subjects who were enrolled for health check-up at UMMC
were approached to participate in this study. All participants
enrolled in this study were Malaysian aged 30–70 years in which
non-probability sampling was used. Venus blood (10ml) was
collected from each participant after obtaining the consent form.
WinPepi program was used to calculate the sample size for control
and case group based on multiple logistic regression at significant
level of 0.05, and 85% power to detect a week association (multiple
correlation coefficient, 0.25). The maximum number was for the
recessive genotypes of rs16860234 (582 subjects in each group).
Demographic and Biochemical Analysis
Fasting plasma glucose (FPG), high density lipoprotein choles-
terol (HDLc), and triglycerides (TG) were measured by an
automated analyzer DimensionH RxL MaxH Integrated Chemistry
System (Siemens Healthcare Diagnostics Inc., Deerfield, IL USA).
Fasting plasma insulin (FPI) was measured by ADVIA Centaur
assay XP Immunoassay System (Siemens Healthcare Diagnostics
Inc. Deerfield, IL USA). Normal and pathological controls were
included with each run of biochemical analysis. GADA were
analyzed by ELISA kit RSR GAD65 autoantibody (GAD Ab)
(RSR Limited, Cardiff, UK). The analysis was done manually
according to the manufacturer’s protocol. Plates were read at
450 nm using a microplate reader (BioRad, Calabasas, USA).
GADA Positive and negative controls were included with each
run. Blood pressure (BP) and waist parameter were measured
using standardized protocols. HOMA-b (a measure of b-cell
function) and HOMA-IR (a measure of insulin resistance) were
calculated using the Homeostasis Model Assessment (HOMA2)
Calculator v2.2, which is available online from Oxford Center for
Diabetes, Endocrinology and Metabolism.
SNPs Selection and Genotyping
IGF2BP2 alternative variant; rs6777038, rs16860234 and
rs7651090 were selected based on [28,30] studies. The
rs7651090 is a tag SNP which is highly linked with the most
common IGF2BP2 variants SNPs rs4402960 and rs1470579 [31].
The rs6777038 and rs16860234 are tag SNPs for haplotype blocks
among Asians. Genomic DNA was isolated from peripheral blood
leukocytes by using a commercially WizardH Genomic DNA
Purification Kit (Promega Corporation, Madison, WI, USA)
according to the manufacturer’s protocol. The IGF2BP2 SNPs
(rs6777038, rs16860234 and rs7651090) were genotyped by pre-
design Taqman genotype assay (Applied Biosystems Inc, Foster
City, USA) according to the manufacturer’s protocol using the
StepOnePlus Real-Time PCR system (Applied Biosystems Inc,
Foster City, USA). The call rates for genotyping were more than
98.5%. To ensure the accuracy, 10% of the samples were re-
genotyped; the SNPs genotypes were 100% concordant. No
template controls (NTC) were included in each run of real time
PCR, which indicated there was no DNA contamination.
Statistical Analysis
Demographic and biochemical parameters were log-trans-
formed before statistical analyses and then re-transformed back
and presented as geometric means. Hardy–Weinberg equilibrium
analyses were performed with DeFinetti program (http://ihg.gsf.
de/cgi-bin/hw/hwa1.pl) (Institute of Human Genetics). SNP &
Variation Suite v7.x (Golden Helix, Bozeman, MT, USA) was
used to study the linkage disequilibrium (LD) between SNPs and
construct haplotypes and diplotypes of related SNPs. The
Table 1. Association of IGF2BP2 polymorphism with GADA negative diabetes among Malaysian subjects and ethnic groups.
IGF2BP2 SNPs Control GADA negative diabetes Recessive Dominant Additive
OR (95% CI)
Freq. 11/12/22 Freq. 11/12/22 P-Value
rs6777038 (C,T)
Combined* 0.29 305/258/47 0.33 479/517/104 1.25(0.85–1.85) 0.25 1.27(1.02–1.58) 0.03 1.21(1.02–1.44) 0.03
Malay# 0.28 132/99/20 0.30 202/187/34 0.83(0.44–1.55) 0.55 1.08(0.76–1.54) 0.67 1.01(0.76–1.32) 0.97
Chinese# 0.21 123/74/5 0.27 148/129/13 2.39(0.76–7.54) 0.14 1.75(1.16–2.62) 0.007 1.69(1.18–2.42) 0.004
Indian# 0.41 50/85/22 0.41 129/201/57 1.15(0.66–2.00) 0.61 0.97(0.65–1.47) 0.89 1.04(0.78–1.38) 0.80
rs16860234 (A,C)
Combined* 0.24 356/210/41 0.30 559/414/124 2.06(1.36–3.12) 0.001 1.35(1.09–1.69) 0.01 1.36(1.14–1.61) 0.0004
Malay# 0.22 153/85/12 0.28 224/160/37 2.55(1.19–5.48) 0.02 1.40(0.98–2.01) 0.07 1.43(1.07–1.91) 0.01
Chinese# 0.18 138/53/9 0.24 182/77/30 3.12(1.30–7.49) 0.01 1.41(0.92–2.16) 0.11 1.47(1.05–2.05) 0.02
Indian# 0.36 65/72/20 0.38 153/177/57 1.26(0.71–2.25) 0.43 1.12(0.76–1.65) 0.57 1.12(0.85–1.49) 0.42
rs7651090 (A,G)
Combined* 0.32 292/249/67 0.38 452/462/183 1.82(1.30–2.53) 0.0004 1.38(1.11–1.71) 0.004 1.35(1.16–1.58) 0.0002
Malay# 0.31 119/107/25 0.35 181/184/55 1.46(0.84–2.56) 0.18 1.39(0.97–1.99) 0.07 1.30(0.99–1.69) 0.06
Chinese# 0.22 123/68/9 0.26 166/98/25 2.46(1.07–5.64) 0.03 1.34(0.89–2.02) 0.15 1.39(1.01–1.92) 0.046
Indian# 0.45 50/74/33 0.50 105/180/103 1.56(0.97–2.50) 0.07 1.30(0.86–1.97) 0.22 1.29(0.99–1.69) 0.06
Risk allele is denoted in boldface. *Controlled for age, race, gender and BMI. #Controlled for age, gender and BMI. The outliers (studentized residual is greater than 2.0
or less than 22.0) were excluded Freq., risk allele frequency. 11, homozygous of major allele; 12, heterozygous; 22, homozygous of minor allele. GADA, glutamic acid
decarboxylase antibodies.
doi:10.1371/journal.pone.0045573.t001
IGF2BP2 Alternative Variants and GADA Negative T2D
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Figure 1. Pairwise linkage disequilibrium among IGF2BP2 SNPs in Malaysian subjects.
doi:10.1371/journal.pone.0045573.g001
Table 2. Association of common haplotypes and diplotypes with GADA negative diabetes among Malaysian subjects.
rs6777038,
rs16860234, rs7651090 Frequency P-Value OR (95% CI)
Control GADA negative diabetes
Haplotypes
TCG 0.26 0.30 0.11 1.22(0.96–1.55)
CAA 0.34 0.26 0.001 0.67(0.53–0.84)
CCG 0.13 0.17 0.01 1.51(1.10–2.06)
TAA 0.11 0.13 0.29 1.20(0.86–1.67)
TAG 0.10 0.09 0.92 0.98(0.68–1.41)
CAG 0.03 0.03 0.60 1.20(0.61–2.35)
Diplotypes
CAA-CAA 0.34 0.26 0.001 0.67(0.53–0.84)
CAA-TCG 0.17 0.17 0.54 0.92(0.69–1.21)
CAA-TAA 0.10 0.12 0.36 1.17(0.84–1.64)
CAA-CCG 0.09 0.10 0.20 1.27(0.88–1.85)
CAA-TAG 0.08 0.07 0.70 0.93(0.62–1.38)
CCG-TCG 0.03 0.04 0.009 2.36(1.24–4.47)
Controlled for age, gender, race and BMI. The outliers (studentized residual is greater than 2.0 or less than 22.0) were excluded. GADA, glutamic acid decarboxylase
antibodies.
doi:10.1371/journal.pone.0045573.t002
IGF2BP2 Alternative Variants and GADA Negative T2D
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statistical analyses were conducted using Social Package of
Statistical Science (SPSS) 11.5 (LEAD Technologies; Inc. USA).
Associations of IGF2BP SNPs, recessive, dominant and additive
genetic models, haplotypes and diplotypes with T2D were
evaluated by logistic regression controlled for age, gender and
body mass index. The significance level was considered P,0.05.
Results
A total of 1140 patients with T2D and 973 non-diabetic control
subjects were included in this study. The GADA analysis on the
diabetics revealed 33 GADA positive diabetic patients; (LADA
patients) thus; they were excluded from further analysis. Applica-
tion of the new metabolic syndrome (MetS) criteria [32] on non-
diabetic control subjects showed 353 subjects had metabolic
Table 3. Association of common haplotypes and diplotypes with GADA negative diabetes among Malaysian races.
rs6777038, rs16860234,
rs7651090 Control GADA negative diabetes
Malay (n=254) Chinese (n =204) Indian (n =162) Malay (n =425) Chinese (n=293) Indian (n=389)
Haplotypes
TCG Freq. 0.22 0.17 0.42 0.27 0.22 0.39
OR (95% CI) 1.23(0.81–1.87) 1.62(0.98–2.69) 0.91(0.62–1.34)
P-Value 0.32 0.06 0.65
CAA Freq. 0.35 0.44 0.20 0.28 0.37 0.16
OR (95% CI) 0.65(0.45–0.95) 0.67(0.45–1.01) 0.72(0.44–1.18)
P-Value 0.028 0.06 0.19
CCG Freq. 0.15 0.10 0.12 0.18 0.11 0.20
OR (95% CI) 1.49(0.92–2.43) 0.93(0.49–1.78) 2.08(1.16–3.72)
P-Value 0.11 0.83 0.01
TAA Freq. 0.10 0.13 0.09 0.13 0.16 0.11
OR (95% CI) 1.21(0.70–2.10) 1.25(0.72–2.18) 1.18(0.62–2.26)
P-Value 0.49 0.43 0.62
TAG Freq. 0.11 0.07 0.10 0.09 0.08 0.10
OR (95% CI) 0.86(0.49–1.51) 1.31(0.60–2.85) 1.07(0.57–2.02)
P-Value 0.59 0.50 0.84
CAG Freq. 0.03 0.03 0.02 0.03 0.02 0.03
OR (95% CI) 2.28(0.74–7.05) 0.58(0.18–1.87) 1.53(0.41–5.65)
P-Value 0.15 0.36 0.53
Diplotypes
CAA-CAA Freq. 0.35 0.44 0.20 0.28 0.37 0.16
OR (95% CI) 0.65(0.45–0.95) 0.67(0.45–1.01) 0.72(0.44–1.18)
P-Value 0.028 0.06 0.19
CAA-TCG Freq. 0.14 0.13 0.28 0.16 0.13 0.21
OR (95% CI) 0.99(0.60–1.61) 1.09(0.61–1.94) 0.69(0.45–1.07)
P-Value 0.96 0.78 0.10
CAA-TAA Freq. 0.10 0.12 0.08 0.12 0.15 0.10
OR (95% CI) 1.17(0.67–2.02) 1.16(0.66–2.04) 1.24(0.64–2.42)
P-Value 0.59 0.60 0.53
CAA-CCG Freq. 0.11 0.08 0.06 0.14 0.04 0.11
OR (95% CI) 1.65(0.95–2.87) 0.49(0.21–1.13) 2.45(1.07–5.63)
P-Value 0.07 0.09 0.035
CAA-TAG Freq. 0.09 0.06 0.07 0.07 0.07 0.08
OR (95% CI) 0.75(0.40–1.40) 1.33(0.59–2.99) 1.05(0.52–2.12)
P-Value 0.37 0.50 0.89
CCG-TCG Freq. 0.02 0.03 0.04 0.04 0.03 0.06
OR (95% CI) 3.59(1.16–11.09) 1.75(0.52–5.89) 1.96(0.72–5.31)
P-Value 0.026 0.37 0.19
Controlled for age, gender and BMI. The outliers (studentized residual is greater than 2.0 or less than 22.0) were excluded. GADA, glutamic acid decarboxylase
antibodies.
doi:10.1371/journal.pone.0045573.t003
IGF2BP2 Alternative Variants and GADA Negative T2D
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syndrome; consequently, they were excluded from subsequent
analysis. Hence, 1107 GADA negative diabetes aged 49.5 years
(61.6% male and 38.4% female) (target group) and 620 normal
subjects without diabetes and MetS aged 51.3 years (67.6% male
and 32.4% female) (control group) were recruited in this study.
The metabolic and diabetic parameters were significantly different
between the target and control groups (Table S1).
The IGF2BP2 SNPs; rs6777038, rs16860234 and rs7651090
did not deviated from Hardy-Weinberg Equilibrium (P-val-
ue = 0.49, 0.18, 0.22 in the control group respectively). The
logistic regression model (adjusted for age, race, gender and BMI)
showed that rs6777038, rs16860234 and rs7651090 were signif-
icantly associated with GADA negative diabetes (additive,
OR=1.21; 1.36; 1.35, P= 0.03; 0.0004; 0.0002, respectively)
(Table 1). Analysis for the association of these SNPs with diabetes
among the three main Malaysian races (Malay, Chinese and
Indian) revealed that rs6777038, rs16860234 and rs7651090 were
associated with diabetes among Malaysian Chinese (Additive,
OR=1.69; 1.47; 1.39, P= 0.004; 0.02; 0.046, respectively), while
only rs16860234 showed a significant association among Malay-
sian Malay (additive, OR=1.43, P = 0.01) with diabetes. In
Malaysian Indian, the rs7651090 showed a border line association
(additive, OR=1.29, P= 0.06) with diabetes (Table 1).
Three-SNP haplotype and diplotype blocks were identified with
significant LD and constructed from the SNPs included in this
study (Figure 1). The most common haplotypes and diplotypes are
depicted in table 2 (combined races) and in table 3 (three main
Malaysian races). The haplotypes and diplotypes with frequency
,2% in total sample were excluded from subsequent analysis. The
logistic regression model (adjusted for age, race, gender and BMI)
showed that the frequency of haplotype CAA was significantly
higher in normal subjects compared to diabetic group (OR=0.67,
P = 0.001), particularly in Malay subjects (OR=0.65, P= 0.028)
(Table 2 and 3).
The haplotype TCG containing the risk alleles of the SNPs,
showed a borderline risk for diabetes in Chinese (OR=1.62,
P = 0.06). However, the haplotype CCG revealed significant
association with diabetes (OR=1.51, P= 0.01) and this risk of
association was higher in diabetic Indian (OR=2.08, P= 0.01)
subjects.
The frequency of diplotype CAA-CAA was higher in normal
subjects compared to diabetic subjects (OR=0.67, P= 0.001)
(Table 2), particularly in Malay subjects (OR=0.65, P= 0.028)
(Table 3). The diplotype CCG-TCG was a risk for diabetes
(OR=2.36, P= 0.009) and the association was higher in diabetic
Malay (OR=3.59, P = 0.026) subjects. The diplotype CAA-CCG
showed a risk for diabetic Indian (OR=2.45, P= 0.035) subjects,
whereas the other diplotypes had no significant association with
T2D.
Discussion
The association of IGF2BP2 alternative variants; rs7651090,
rs16860234 and rs6777038 with GADA negative diabetes was
evaluated in Malaysian subjects. To the best of our knowledge, this
is the first study to be performed in Southeast Asia. The strongest
association was found at rs7651090 followed by rs16860234 then
rs6777038. These SNPs showed an association in Malaysian
subjects particularly in Chinese. This is in agreement with Hu et al.
[28] who showed an association of rs7651090 with Chinese and in
disagreement with Rong et al. [30] who showed no association of
rs6777038 and rs16860234 SNPs with Pima Indians. This may be
attributed gene–gene and gene–environmental interactions that
may have contributed to many of the reported differences in gene–
disease associations between different racial or ethnic groups [33].
Another opinion attributed this to ethnic differences and linkage
disequilibrium pattern, compounded by the contribution of non-
genetic factors and lifestyle changes that can modify the risk of
T2D [20].
Several studies suggested the predominant contribution of the
IGF2BP2 variants to T2D was mediated through defects in insulin
secretion rather than action [34,35]. However, none of these SNPs
showed an association with HOMA-B or HOMA-IR (data not
shown). A similar finding was reported in a previous studies [28].
Thus, the effects of these SNPs on diabetes and metabolic
syndrome in the Asian might still need further investigations. The
haplotype (CCG) and diplotype (CCG-TCG) showed a stronger
association with GADA negative diabetes than single individual
SNPs. This prompts speculation of possible epistatic interaction
between these SNPs in determining overall risk of T2D [20]. This
study was a hospital-based and the sampling method was non-
probability thus the finding of this study limited its generalization
to whole Malaysian population. Sub-grouping of subjects accord-
ing to races resulted in small sample size particularly in Indian
subjects.
In conclusion, IGF2BP2 alternative variants were associated
with GADA negative diabetes in Malaysian subjects. The risk of
these variants was different among the three main Malaysian races
Moreover, certain IGF2BP2 haplotypes and diplotypes strengthen
the risk of diabetes.
Supporting Information
Table S1 Demography and biochemical parameters.
(DOCX)
Acknowledgments
We thank all the participants of this research and all nursing and medical
staff at UMMC for their dedication in this study.
Author Contributions
Conceived and designed the experiments: SDS RSA SM. Performed the
experiments: SDS. Analyzed the data: SDS RSA. Contributed reagents/
materials/analysis tools: SDS ISI ZA RP. Wrote the paper: SDS SM ISI.
References
1. IDF (2011) International Diabetes Federation Diabetes Atlas. 5th edition ed.
2. Turner R, Stratton I, Horton V, Manley S, Zimmet P, et al. (1997) UKPDS 25:
autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for
prediction of insulin requirement in type 2 diabetes. The Lancet 350: 1288–
1293.
3. Monge L, Bruno G, Pinach S, Grassi G, Maghenzani G, et al. (2004) A clinically
orientated approach increases the efficiency of screening for latent autoimmune
diabetes in adults (LADA) in a large clinic-based cohort of patients with diabetes
onset over 50 years. Diabet Med 21: 456–459.
4. Roh M-O, Jung C-H, Kim B-Y, Mok J-O, Kim C-H (2010) The prevalence and
characteristics of latent autoimmune diabetes in adults (LADA) and its relation
with chronic complications in a clinical department of a university hospital in
Korea. Acta Diabetologica: 1–6.
5. Groop LC, Bottazzo GF, Doniach D (1986) Islet cell antibodies identify latent
type I diabetes in patients aged 35–75 years at diagnosis. Diabetes 35: 237–241.
6. Stenstro¨m G, Gottsa¨ter A, Bakhtadze E, Berger B, Sundkvist G (2005) Latent
Autoimmune Diabetes in Adults. Diabetes 54: S68–S72.
IGF2BP2 Alternative Variants and GADA Negative T2D
PLOS ONE | www.plosone.org 5 September 2012 | Volume 7 | Issue 9 | e45573
7. Tuomi T, Carlsson A, Li H, Isomaa B, Miettinen A, et al. (1999) Clinical and
genetic characteristics of type 2 diabetes with and without GAD antibodies.
Diabetes 48: 150–157.
8. Jin W, Patti ME (2009) Genetic determinants and molecular pathways in the
pathogenesis of Type 2 diabetes. Clin Sci (Lond) 116: 99–111.
9. Permutt MA, Wasson J, Cox N (2005) Genetic epidemiology of diabetes. The
Journal of Clinical Investigation 115: 1431–1439.
10. Jia H, Yu L, Jiang Z, Ji Q (2011) Association between IGF2BP2 rs4402960
polymorphism and risk of type 2 diabetes mellitus: a meta-analysis. Arch Med
Res 42: 361–367.
11. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, et al. (2007) A genome-wide
association study identifies novel risk loci for type 2 diabetes. Nature 445: 881–
885.
12. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, et al. (2007) A genome-
wide association study of type 2 diabetes in Finns detects multiple susceptibility
variants. Science 316: 1341–1345.
13. Takeuchi F, Serizawa M, Yamamoto K, Fujisawa T, Nakashima E, et al. (2009)
Confirmation of multiple risk Loci and genetic impacts by a genome-wide
association study of type 2 diabetes in the Japanese population. Diabetes 58:
1690–1699.
14. Hinohara K, Nakajima T, Sasaoka T, Sawabe M, Lee BS, et al. (2009)
Replication studies for the association of PSMA6 polymorphism with coronary
artery disease in East Asian populations. J Hum Genet 54: 248–251.
15. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, et al. (2007)
Genome-wide association analysis identifies loci for type 2 diabetes and
triglyceride levels. Science 316: 1331–1336.
16. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, et al. (2007)
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk
Loci for Type 2 Diabetes. Science 316: 1336–1341.
17. Consortium TWTCC (2007) Genome-wide association study of 14,000 cases of
seven common diseases and 3,000 shared controls. Nature 447: 661–678.
18. Le HTT, Sorrell AM, Siddle K (2012) Two Isoforms of the mRNA Binding
Protein IGF2BP2 Are Generated by Alternative Translational Initiation. PLoS
ONE 7: e33140.
19. Rodriguez S, Eiriksdottir G, Gaunt TR, Harris TB, Launer LJ, et al. (2010)
IGF2BP1, IGF2BP2 and IGF2BP3 genotype, haplotype and genetic model
studies in metabolic syndrome traits and diabetes. Growth Hormone & IGF
Research 20: 310–318.
20. Nemr R, Echtay A, Dashti EA, Almawi AW, Al-Busaidi AS, et al. (2012) Strong
association of common variants in the IGF2BP2 gene with type 2 diabetes in
Lebanese Arabs. Diabetes Research and Clinical Practice: 10.1016/j.dia-
bres.2011.1012.1026.
21. Cauchi S, Meyre D, Durand E, Proenc¸a C, Marre M, et al. (2008) Post
Genome-Wide Association Studies of Novel Genes Associated with Type 2
Diabetes Show Gene-Gene Interaction and High Predictive Value. PLoS ONE
3: e2031.
22. Horikawa Y, Miyake K, Yasuda K, Enya M, Hirota Y, et al. (2008) Replication
of Genome-Wide Association Studies of Type 2 Diabetes Susceptibility in Japan.
Journal of Clinical Endocrinology & Metabolism 93: 3136–3141.
23. Han X, Luo Y, Ren Q, Zhang X, Wang F, et al. (2010) Implication of genetic
variants near SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, FTO,
TCF2, KCNQ1, and WFS1 in Type 2 Diabetes in a Chinese population. BMC
Medical Genetics 11: 81.
24. Hertel J, Johansson S, Ræder H, Midthjell K, Lyssenko V, et al. (2008) Genetic
analysis of recently identified type 2 diabetes loci in 1,638 unselected patients
with type 2 diabetes and 1,858 control participants from a Norwegian
population-based cohort (the HUNT study). Diabetologia 51: 971–977.
25. Lee Y-H, Kang ES, Kim SH, Han SJ, Kim CH, et al. (2008) Association
between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO,
WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population.
J Hum Genet 53: 991–998.
26. Ng MC, Park KS, Oh B, Tam CH, Cho YM, et al. (2008) Implication of genetic
variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2,
and FTO in type 2 diabetes and obesity in 6,719 Asians. Diabetes 57: 2226–
2233.
27. Wu Y, Li H, Loos RJF, Yu Z, Ye X, et al. (2008) Common Variants in
CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE Genes Are
Associated With Type 2 Diabetes and Impaired Fasting Glucose in a Chinese
Han Population. Diabetes 57: 2834–2842.
28. Hu C, Zhang R, Wang C, Wang J, Ma X, et al. (2009) PPARG, KCNJ11,
CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 Are
Associated with Type 2 Diabetes in a Chinese Population. PLoS ONE 4: e7643.
29. Tan JT, Ng DPK, Nurbaya S, Ye S, Lim XL, et al. (2010) Polymorphisms
Identified through Genome-Wide Association Studies and Their Associations
with Type 2 Diabetes in Chinese, Malays, and Asian-Indians in Singapore.
Journal of Clinical Endocrinology & Metabolism 95: 390–397.
30. Rong R, Hanson RL, Ortiz D, Wiedrich C, Kobes S, et al. (2009) Association
Analysis of Variation in/Near FTO, CDKAL1, SLC30A8, HHEX, EXT2,
IGF2BP2, LOC387761, and CDKN2B With Type 2 Diabetes and Related
Quantitative Traits in Pima Indians. Diabetes 58: 478–488.
31. Christiansen J, Kolte AM, Hansen TO, Nielsen FC (2009) IGF2 mRNA-binding
protein 2: biological function and putative role in type 2 diabetes. J Mol
Endocrinol 43: 187–195.
32. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, et al. (2009)
Harmonizing the metabolic syndrome: a joint interim statement of the
International Diabetes Federation Task Force on Epidemiology and Prevention;
National Heart, Lung, and Blood Institute; American Heart Association; World
Heart Federation; International Atherosclerosis Society; and International
Association for the Study of Obesity. Circulation 120: 1640–1645.
33. Moonesinghe R, Ioannidis JPA, Flanders WD, Yang Q, Truman BI, et al. (2012)
Estimating the contribution of genetic variants to difference in incidence of
disease between population groups. Eur J Hum Genet: doi: 10.1038/
ejhg.2012.1015.
34. Grarup N, Rose CS, Andersson EA, Andersen G, Nielsen AL, et al. (2007)
Studies of Association of Variants Near the HHEX, CDKN2A/B, and IGF2BP2
Genes With Type 2 Diabetes and Impaired Insulin Release in 10,705 Danish
Subjects. Diabetes 56: 3105–3111.
35. Grarup N, Andersen G, Krarup NT, Albrechtsen A, Schmitz O, et al. (2008)
Association testing of novel type 2 diabetes risk alleles in the JAZF1, CDC123/
CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 loci with insulin
release, insulin sensitivity, and obesity in a population-based sample of 4,516
glucose-tolerant middle-aged Danes. Diabetes 57: 2534–2540.
IGF2BP2 Alternative Variants and GADA Negative T2D
PLOS ONE | www.plosone.org 6 September 2012 | Volume 7 | Issue 9 | e45573
